Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Permethrin versus dimethicone for head lice in primary school girls
IRCT20171117037512N2Phase 4Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2018
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of permethrin and dimeticone in pediculosis capitis (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Cure rate. Started Feb 2018; status: completed.
02
Drugs
permethrindimeticone
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on IRCT20171117037512N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171117037512N2.